Ozempic® & Semaglutide

1-800-LAW-FIRM is investigating cases where individuals have suffered gastroparesis/stomach paralysis after using the weight loss drugs Ozempic, Wegovy, or Rybelsus because the manufacturer of these drugs failed to adequately warn patients and doctors of the risk of these dangerous gastrointestinal side effects.

If you or a loved one suffered serious health issues like stomach paralysis or intestinal obstructions and were hospitalized or needed a follow-up with a gastroenterologist for your injury, you may have a claim. Call us today at (800) 529-3476 or complete the following form to schedule a FREE, NO OBLIGATION claim review to see if you qualify!

Please enable JavaScript in your browser to complete this form.

First Name *

Last Name *

Phone *

Email *

Who is the free claim review for? *SelfSpouseChildParentOther

Which litigation are you interested in discussing? *Bard PowerPort CatheterCooperSurgical IVF SolutionOzempic® & SemaglutideSuboxone®

What Date & Time (EST) would you like to schedule your free claim review? *

Date

Time

Please provide us with any information regarding your potential claim *

Consent Acknowledgement *

• By checking this box, I acknowledge and consent that the email address & phone number I have provided may be used to contact me by 1-800-LAW-FIRM or their partner law firms (including autodialed, pre-recorded calls or text messages).

Submit

Ozempic contains semaglutide to help regulate blood sugar levels and increase the secretion of insulin, which can leave patients feeling full or satisfied. As a result, many patients use Ozempic and other semaglutide medications like Wegovy and Rybelsus for weight loss.

However, recent studies have shown that semaglutide drugs like Ozempic may increase the risk of stomach paralysis (gastroparesis), bowel obstruction, deep vein thrombosis (DVT), malnutrition-related disorders, and other health issues.

The U.S. Food and Drug Administration (FDA) has received adverse event reports of gastroparesis/stomach paralysis from individuals who took the GLP-1 Receptor Agonists (RA) drugs.

The first such GLP-1 RA drug lawsuit filed involved a woman who began receiving Ozempic injections in the spring of 2022. According to the plaintiff, within two years’ time, she was suffering from severe stomach paralysis. Switching to another medication, Mounjaro, did not alleviate her symptoms.

Novo Nordisk, the maker of these weight-loss drugs, does not include warnings about the increased risk of gastroparesis/stomach paralysis for people who consume the medications or receive GLP-1 RA treatments.

The use of Ozempic has been associated with the following health issues, that users should be aware of before taking this medication

• Stomach paralysis (gastroparesis)
• Bowel or intestinal obstructions
• Chronic vomiting
• Deep vein thrombosis (DVT)
• Esophageal injury
• Ileus (intestinal inability to contract and pass waste)
• Intraoperative pulmonary aspiration
• Malnutrition-related disorders
• Pancreatic cancer

Sadly, many of these side effects may be severe and require hospitalization or additional medical care.

Because the warning labels on these medications may not have mentioned all of the side effects, anyone who’s been impacted may be able to pursue a claim against the manufacturers if you or a loved one:

• Used a semaglutide drug like Ozempic, Wegovy, or Rybelsus for weight loss
• Suffered serious health issues like stomach paralysis, intestinal obstructions, or more
• Was hospitalized, went to the ER, or needed a follow-up with a gastroenterologist for your injury